Clinical Advances in
Patients with dementia and symptoms of psychosis are at risk for poor quality of life and early institutionalization. Limited current clinical guidance and evidence on the clinical efficacy of commonly used antipsychotics can make it a challenge for clinicians to diagnose and treat these patients. This collection provides vital information on the pathophysiology of dementia-related psychosis (DRP), strategies for diagnosing and managing patients with DRP, and the latest data on available and investigational therapies.
Supported by an independent educational grant from
ACADIA Pharmaceuticals Inc.
Steering Committee Chair
Research Professor of Psychiatry
University of Arizona College of Medicine
Director Banner Alzheimer's Institute
Phoenix, Arizona
Professor of Psychiatry and Neurology
Columbia University
New York, New York
Samuel W. Fordyce Professor
Director, Geriatric Psychiatry
St Louis University School of Medicine
St Louis, Missouri
Clinical Professor of Psychiatry
University of California, San Diego
La Jolla, California
Friends of Alzheimer's Research Endowed Professor of Psychiatry
Washington University School of Medicine
St. Louis, Missouri
Professor of Psychiatry & Biobehavioral Sciences
Parlow Solomon Professor on Aging
Director, UCLA Longevity Center
University of California, Los Angeles